ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 16

$457K Total Retail Price of All Prescriptions

Rank: 10 out of 16

528 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

17% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 7,441 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 37.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 610 542 1 5
LISINOPRIL 349 296 2 4
LEVOTHYROXINE SODIUM 349 290 2 1
HYDROCODONE-ACETAMINOPHEN 317 205 S3 4 3
OMEPRAZOLE 298 255 5 8
METOPROLOL TARTRATE 293 268 6 10
METFORMIN HCL 248 209 7 15
AMLODIPINE BESYLATE 247 219 8 7
FUROSEMIDE 247 221 8 2
POTASSIUM CHLORIDE 234 197 10 6
TRAMADOL HCL 210 96 11 19
GABAPENTIN 184 141 12 12
MELOXICAM 174 158 13 52
TRAZODONE HCL 164 109 14 20
HYDROCHLOROTHIAZIDE 162 150 15 25
CARVEDILOL 122 107 16 18
TAMSULOSIN HCL 120 110 17 29
LOSARTAN POTASSIUM 117 107 18 34
RANITIDINE HCL 109 70 19 17
METOPROLOL SUCCINATE 103 102 20 24
CYCLOBENZAPRINE HCL 92 37 R 21 98
ZOLPIDEM TARTRATE 89 65 22 32
ALLOPURINOL 87 74 23 50
ATENOLOL 86 54 24 26
FINASTERIDE 77 77 25 73
CLOPIDOGREL 75 65 26 28
LOSARTAN-HYDROCHLOROTHIAZIDE 72 63 27 89
PROAIR HFA 72 23 27 86
LOVASTATIN 68 54 29 40
WARFARIN SODIUM 66 66 30 9
PREDNISONE 65 58 31 42
GLYBURIDE 62 40 R 32 109
IBUPROFEN 58 35 33 153
CITALOPRAM HBR 58 34 33 16
ADVAIR DISKUS 57 41 35 56
COMBIVENT 56 37 36 151
ESTRADIOL 55 42 R 37 208
BENAZEPRIL HCL 53 50 38 113
ATORVASTATIN CALCIUM 53 34 38 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 39 40 84
AMLODIPINE BESYLATE-BENAZEPRIL 51 48 41 149
OXYCODONE-ACETAMINOPHEN 51 18 S2 41 64
DIOVAN 50 47 43 60
METOCLOPRAMIDE HCL 50 33 43 94
LANTUS 50 46 43 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.